We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
iMediSync aMCI Report - Pay-per-use
- This screening has not yet received FDA approval.
- aMCI Report not meant to be used as a diagnostic tool
- Requires iSyncBrain subscription to generate this report
Our Part #
IMS AMCI-SCREEN
In Stock
Only %1 left
As low as
$3,800.00
The aMCI (amnestic mild cognitive impairment) screening utilizes an AI trained on EEG data of patients diagnosed with aMCI to make a prediction of aMCI likelihood. The data used in training included patients from 50 years old to eighty-five, and therefore is only accurate for patients in that age range.
You must have an iSyncBrain subscription to generate this report.
This screening has not yet received FDA approval and it can not be charged to insurance. It is not meant to be used as a diagnostic tool. The screening makes recommendations on next steps determined by the AI’s prediction.
The small star on the prediction chart is where the patient lies according to the AI. Anything below 50% is normal. Anything higher is differentiated based on predicted aMCI severity or type. The AI’s latest test showed 91% prediction accuracy.
Write Your Own Review
Manuals and Data Sheets
Product Brand
BENEFITS FOR SIGNING IN
FREE GROUND SHIPPING
on USA orders $100+ & CAN $200+
INSTANT SAVINGS
Save 2% right away on most items
EARN MORE SAVINGS
Growing your savings up to 10% off